Dr. Nicholas J. Vogelzang is the Chair and Medical Director of the Developmental, Therapeutic Committee and Co-Chair Genitourinary Oncology, at the US Oncology Research Center, in Houston, TX.
He is also Medical Oncologist at the Comprehensive Cancer Centers of Nevada, Las Vegas, NV.
Dr. Vogelzang is specialized in Internal Medicine and Medical Oncology. He is also a Diplomat of National Board of Medical Examiners.
He is very active in societies like: American Association of Cancer Research, American College of Physicians, American Society of Clinical Oncology, Chicago Urological Society, Mesothelioma
Foundation, Nevada Oncology Society and others.
Dr. Vogelzang1s major medical interests are: in mesothelioma, malignancies and clinical trials in genitourinary, genitourinary malignancies.
Dr. Vogelzang in known to be an expert in new therapies for cancer patients, and he is also known for his large scale clinical trials regarding prostate cancer and mesothelioma cancer.
He is also a cancer researcher who co-authored numerous books and articles regarding his studies and his results related to cancer disorders treated by him. He become interested in mesothelioma cancer many years ago and for over 15 years he saw many and helped many mesothelioma patients during his work at the mesothelioma research program of Cancer and Leukemia Group B, a national research cancer organization. He developed new techniques for measuring and tracking the response of mesothelioma to chemotherapy.Contact mesothelioma doctors today and start with the right treatment!
Mesothelioma (cancer of the mesothelium) is a disease in which cells of the mesothelium become abnormal and divide without control or order. They can invade and damage nearby tissues and organs. Cancer cells can also metastasize (spread) from their original site to other parts of the body. Most cases of mesothelioma begin in the pleura or peritoneum.
Test Test